You are here » Home » Company » Neuland Laboratories Ltd

Neuland Laboratories Ltd.

BSE: 524558 Sector: Health care
NSE: NEULANDLAB ISIN Code: INE794A01010
BSE 00:00 | 19 Aug 502.80 -2.05
(-0.41%)
OPEN

505.05

HIGH

513.90

LOW

500.85

NSE 00:00 | 19 Aug 503.45 -0.85
(-0.17%)
OPEN

512.00

HIGH

519.35

LOW

501.00

OPEN 505.05
PREVIOUS CLOSE 504.85
VOLUME 503
52-Week high 824.55
52-Week low 431.45
P/E 30.22
Mkt Cap.(Rs cr) 645
Buy Price 496.00
Buy Qty 1.00
Sell Price 515.00
Sell Qty 9.00
OPEN 505.05
CLOSE 504.85
VOLUME 503
52-Week high 824.55
52-Week low 431.45
P/E 30.22
Mkt Cap.(Rs cr) 645
Buy Price 496.00
Buy Qty 1.00
Sell Price 515.00
Sell Qty 9.00

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd

Set up in 1984 as a private limited company to manufacture bulk drugs, Neuland Laboratories (NLL) is promoted by D R Rao. Neuland Drugs & Pharmaceuticals Pvt Ltd, a company set up by the same promoters to manufacture bulk drugs was merged with NLL with effect from Apr.'92. NLL manufactures bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. ...> More

Neuland Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   645
EPS - TTM () [*S] 16.64
P/E Ratio (X) [*S] 30.22
Face Value ()   10
Latest Dividend (%)   12.00
Latest Dividend Date 27 Jun 2019
Dividend Yield (%) 0.24
Book Value / Share () [*S] 541.45
P/B Ratio () [*S] 0.93
[*C] Consolidated     [*S] Standalone    

Neuland Laboratories Ltd - Financial Results

Particulars ( cr) Jun 2019 Jun 2018 % Chg
Net Sales 181.01 153.96 17.57
Other Income 0.52 1.11 -53.15
Total Income 181.53 155.07 17.06
Total Expenses 162.34 144.82 12.1
Operating Profit 19.18 10.25 87.12
Net Profit 5.71 0.57 901.75
Equity Capital 12.9 12.9 -
> More on Neuland Laboratories Ltd Financials Results

Neuland Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
DIL 900.15 2.81 826.34
Morepen Labs. 17.30 2.37 778.24
TTK Healthcare 470.05 -3.97 664.18
Neuland Labs. 502.80 -0.41 645.09
Marksans Pharma 15.50 3.33 634.42
Medicamen Biotec 399.05 2.93 487.64
Gufic BioScience 61.20 11.88 476.14
> More on Neuland Laboratories Ltd Peer Group

Neuland Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 35.90
Banks/FIs 0.06
FIIs 14.89
Insurance 0.00
Mutual Funds 3.92
Indian Public 20.07
Custodians 0.00
Other 6.25
> More on Neuland Laboratories Ltd Share Holding Pattern

Neuland Laboratories Ltd - Research Reports

Date Broker Action Price Report
20/05 HDFC Securities Buy 669 PDF IconDetails
> More on Neuland Laboratories Ltd Research Reports

Neuland Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 9.01% 8.56% -0.48% -0.50%
1 Month 0.30% 0.65% -2.44% -3.20%
3 Month -24.70% -24.76% -1.39% -3.10%
6 Month -10.39% -9.91% 5.80% 4.24%
1 Year -26.85% -26.53% -1.44% -3.63%
3 Year -46.99% -46.98% 33.21% 27.54%

Neuland Laboratories Ltd - STOCK STRENGTH

Today's Low/High 500.85
513.90
Week Low/High 454.90
530.00
Month Low/High 445.00
540.00
YEAR Low/High 431.45
825.00
All TIME Low/High 13.63
1680.00